EIT Health
Biotech Certified Innovation Path
Application platform opens 15 July 2026
Last verified:
The Biotech Certified Innovation Path, funded by EIT Health, supports consortia to design and deliver certified personalised learning courses in health biotechnology covering innovation, entrepreneurship, and translational expertise. Awards up to €240,000 per project to teams of at least two higher education institutions (HEIs) across different EU Member States plus at least one industry or non-academic partner. This is a one-off call emphasising multi-disciplinary, cross-border curriculum development with EIT Label certification and ECTS credit accreditation.
Details
| Funder | EIT Health |
| Budget | Up to €240,000 per project |
| Deadline | 16 September 2026 |
| Consortium | Required — minimum 2 HEIs from 2 different eligible EU Member States, plus at least 1 non-academic/industry partner; at least 1 HEI must be in an EIT RIS region |
| Application | Single stage |
| Frequency | One-off |
Eligibility & scope
Consortium of ≥2 HEIs in ≥2 eligible EU Member States (at least one in an EIT RIS region) plus ≥1 industry/non-academic partner. Funds design and delivery of EIT Label-certified personalised learning courses in health biotechnology (innovation, entrepreneurship, regulatory/translational expertise). At least one HEI must be authorised to award ECTS credits.
Who Should Apply
- •Consortia of at least 2 HEIs from different eligible EU Member States (at least one in an EIT RIS region)
- •At least one HEI with authority to award ECTS credits
- •Teams including at least one industry partner or non-academic organisation
- •Institutions ready to collaborate on EIT Label-certified course design and delivery in biotechnology
Key Dates
- •Application platform opens 15 July 2026; deadline 16 September 2026
- •Single-stage evaluation
Tips for Applicants
- ✓EIT RIS eligibility is gating, at least one HEI must be in an EIT Regional Innovation Scheme region; verify your partner institution's status before submitting.
- ✓ECTS accreditation is non-negotiable; ensure one partner has the regulatory authority to award credits and confirms this in writing.
- ✓The industry partner's letter should outline their role in course design and delivery, not just endorsement; EIT Health values hands-on engagement from the non-academic sector.
Frequently Asked Questions
How much funding does the Biotech Certified Innovation Path provide?
Up to €240,000 per project.
Who must be part of the consortium for the Biotech Certified Innovation Path?
At least 2 HEIs from different eligible EU Member States (one in an EIT RIS region), plus at least 1 industry or non-academic partner; at least one HEI must be authorised to award ECTS credits.
What type of course does the Biotech Certified Innovation Path fund?
EIT Label-certified personalised learning courses in health biotechnology covering innovation, entrepreneurship, and translational or regulatory expertise.
Is the Biotech Certified Innovation Path a recurring call?
No, this is a one-off call.
When does the application platform open for the Biotech Certified Innovation Path?
The platform opens on 15 July 2026, with a deadline of 16 September 2026.
Summary generated by AI based on published grant information. Always verify details on the funder's website.
More from EIT Health
Transformative Healthcare Instrument
Deadline: 16 Sept 2026€300k–€500k (max 50% of total project costs)Innovation Uptake Call
Deadline: 16 Sept 2026Up to €650k per project; total call budget up to €5.2MBiotech Innovation Path Call
Deadline: 16 Sept 2026Up to €240,000 per projectEntrepreneurship & Innovation Micro-Credentials Call
Deadline: 16 Sept 2026Up to €150k in 2027 + up to €60k in 2028Healthcare Regulations: Ensuring Regulatory Compliance by Design
€300 excl. VAT (course fee)
Browse Related
Could Biotech Certified Innovation Path be right for you?
See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →